Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127533801 | 12753380 | 1 | I | 201110 | 20160614 | 20160916 | 20160916 | PER | PL-LUPIN PHARMACEUTICALS INC.-2016-02817 | LUPIN | STOBIECKI M, SACHA M, CZARNOBILSKA E. ANAPHYLAXIS AS PART OF A CLINICAL DIAGNOSIS OF MASTOCYTOSI-CASE DEMONSTRATION.. PRZEGLAD LEKARSKI. 2015;72(12):783-786. | 0.00 | A | F | Y | 0.00000 | 20160914 | OT | PL | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127533801 | 12753380 | 1 | PS | CEFUROXIME. | CEFUROXIME | 1 | Intravenous (not otherwise specified) | UNKNOWN | 65135 | ||||||||||
| 127533801 | 12753380 | 2 | SS | CEFUROXIME. | CEFUROXIME | 1 | Unknown | UNKNOWN | 65135 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127533801 | 12753380 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127533801 | 12753380 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127533801 | 12753380 | Anaphylactic reaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127533801 | 12753380 | 1 | 201110 | 0 | ||
| 127533801 | 12753380 | 2 | 201202 | 0 |